Bay BioSciences provides top quality bio materials and related services to researchers and pharmaceutical companies all over the world.
Bay Biosciences recognize the critical role that stool (feces) biospecimens now play in new frontiers of research-from gut microbiome profiling to infectious disease, metabolic studies, and biomarker development. Our human stool samples are collected under IRB-approved protocols, thoroughly characterized and paired with rich donor metadata, making them ideal for translational research, drug development and clinical studies.
Stool samples can be used in the context of autoimmune diseases by testing for inflammation markers like fecal calprotectin, which indicates gut inflammation and can suggest diseases like Crohn’s or ulcerative colitis.
Additionally, stool analysis also examines gut microbiota and metabolites, which research shows are linked to various autoimmune conditions like rheumatoid arthritis, multiple sclerosis, and lupus. Consequently, this can help identify potential biomarkers for diagnosis, understand the disease’s mechanisms, and evaluate treatment effectiveness.
We offer a wide portfolio of stool biospecimens ready for research use:
Stool samples available for research from following conditions: